Lipitor, a brand name for atorvastatin, is a statin medication used to lower cholesterol levels and prevent cardiovascular disease.

The dosage of Lipitor can vary depending on several factors such as age, weight, and underlying medical conditions. According to the prescribing information, the recommended starting dose of Lipitor is 10 mg once daily [1].

The dosage can be increased in increments of 10 mg every 4 weeks to a maximum dose of 80 mg once daily. However, it's essential to follow the prescribed dosage regimen as directed by your healthcare provider [1].

Increasing the dosage of Lipitor beyond the recommended levels can be potentially beneficial for patients with high cholesterol or those at increased risk of cardiovascular disease [2]. For example, studies have shown that higher doses of atorvastatin (e.g., 80 mg) can lead to greater reductions in LDL ("bad") cholesterol levels and an increased risk of lowering cardiovascular events [3].

However, it's crucial to consult with your healthcare provider before making any changes to your Lipitor dosage. They will assess your individual needs and adjust your dosage accordingly. Patients taking Lipitor should also adhere to a cholesterol-lowering diet and engage in regular physical activity to optimize the medication's effectiveness.

Please note that patients should not attempt to increase their Lipitor dosage on their own, as this can increase the risk of adverse effects, such as muscle damage or liver enzyme elevations [1].

Sources:

[1] Pfizer. (2020). Lipitor (Atorvastatin Calcium) Tablets. Prescribing Information. Retrieved from https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020686s056lbl.pdf

[2] Grundy, S. M., et al. (2004). Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines. Circulation, 110(10), 227), 236. Retrieved from https://www.ahajournals.org/doi/10.1161/01.CIR.0000139770.52391.FC

[3] Cannon, C. P., et al. (2004). Intensive Versus Moderate Lipid Lowering With Statins After Acute Coronary Syndromes. New England Journal of Medicine, 350(15), 1495-1504. Retrieved from https://www.nejm.org/doi/full/10.1056/NEJMoa032177